Sign in
Stories
CDC Expedites Release of Additional Doses of Infant RSV Drug, Measles Comesback Worldwide
Share
COVID-19 Impact on Immunocompromised Pat...
COVID-19 Protection Advancements
COVID-19 Variant Prevalence
CDC Alerts on Rocky Mountain Spotted Fev...
CDC Revises COVID Guidelines
COVID Reporting Requirements Expire
Overview
API
CDC expedites release of additional doses of infant RSV drug to address shortage in the U.S. Measles experiences a comeback worldwide due to declining vaccination rates.
Ask a question
How can the U.S. ensure it meets its target of a 95% vaccination rate?
What are the potential long-term effects of the shortage of the infant RSV drug in the U.S.?
What measures can be taken to increase vaccination rates globally?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Aug 2023
Sep 2023
Oct 2023
Nov 2023
Coverage